Evaluate the immunological responses of human samples collected from phase i and phase II clinical trials of seasonal and pandemic influenza vaccine with and without adjuvant. Clinical trial samples…
Ended Awarded Last action
- Contract number
- 75N93020F00001
- Awardee
-
Battelle Memorial Institute UEI F125YU6SWK59
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,477,748
Award facts
- Opportunity
-
- Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases Pre-Solicitation · Posted Feb 6, 2017
- Contract value 24% obligated
-
- $1,477,748.00 Current, with exercised options
- $6,236,951.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541713 Research and Development in Nanotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Columbus, OH 43201, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,477,748 |
About this award
This is a $6,236,951.00 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Battelle Memorial Institute, a nonprofit research and development organization, to evaluate the immunological responses of human samples collected from Phase I and Phase II clinical trials of seasonal and pandemic influenza vaccines with and without adjuvant. The contract is a cost-plus-fixed-fee type and does not have a set-aside designation. Battelle is frequently awarded prime and subcontracts by federal agencies to provide research, engineering, testing, manufacturing, and IT services across domains like defense, health, and energy. This award is likely part of NIAID's broader efforts to develop and assess new influenza vaccine technologies.
Description
Evaluate the immunological responses of human samples collected from phase i and phase II clinical trials of seasonal and pandemic influenza vaccine with and without adjuvant. Clinical trial samples shall be evaluated using qualified, hemagglutinin i
Quick answers
Who was awarded contract 75N93020F00001?
75N93020F00001 was awarded to Battelle Memorial Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 30, 2019.
How much is contract 75N93020F00001 worth?
The government has obligated $1,477,748 on 75N93020F00001. Its potential value, with all options, is $6,236,951.
Is contract 75N93020F00001 an order under another contract?
Yes. 75N93020F00001 is a delivery order under 75N93018D00013, an indefinite delivery contract.
Was contract 75N93020F00001 competed?
The extent of competition for 75N93020F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award